Evotec SE (EVO) Operating Income (2009 - 2025)
Evotec SE (EVO) reported Operating Income of $44000.8 for Q4 2025, up 635.29% on a YoY basis from $5984.1 in Q4 2024, and up 184.58% sequentially from -$52025.3 in Q3 2025.
Evotec SE (EVO) Operating Income (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Operating Income data on file, last reported at $44000.8 in Q4 2025.
- For the quarter ending Q4 2025, Operating Income rose 635.29% year-over-year to $44000.8; the trailing twelve-month figure through Dec 2025 stood at -$31135.4 (up 35.85% YoY), and the FY2025 full-year result was -$86721.2, down 56850.47% from the prior year.
- Operating Income rose to $44000.8 in Q4 2025, from -$52025.3 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $71672.5 in Q1 2022 to a low of -$52025.3 in Q3 2025.
- A 5-year average of $5966.3 and a median of $8162.6 in 2021 frame the typical range for Operating Income.
- Across the five-year window, Operating Income plunged 882.27% in 2023 and jumped 635.29% in 2025, its largest moves.
- Tracing EVO's Operating Income over 5 years: stood at $29803.9 in 2021, then sank by 157.63% to -$17176.9 in 2022, then plunged by 125.25% to -$38690.8 in 2023, then jumped by 115.47% to $5984.1 in 2024, then jumped by 635.29% to $44000.8 in 2025.
- Business Quant data shows EVO's Operating Income at $44000.8 in Q4 2025, -$52025.3 in Q3 2025, and $5984.1 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Evotec SE | 346.06 Mn | 345.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44,000.84 |
| Sep 30, 2025 | -52,025.29 |
| Dec 31, 2024 | 5,984.13 |
| Sep 30, 2024 | -29,095.13 |
| Dec 31, 2023 | -38,690.80 |
| Sep 30, 2023 | 13,266.65 |
| Jun 30, 2023 | -39,514.89 |
| Dec 31, 2022 | -17,176.88 |
| Sep 30, 2022 | 13,640.94 |
| Jun 30, 2022 | -4,022.80 |
| Mar 31, 2022 | 71,672.49 |
| Dec 31, 2021 | 29,803.88 |
| Sep 30, 2021 | 20,918.20 |
| Jun 30, 2021 | 8,162.55 |
| Mar 31, 2021 | 62,571.09 |
| Dec 31, 2020 | 198,429.22 |
| Sep 30, 2020 | 21,663.16 |
| Dec 31, 2019 | 69.41 Mn |
| Sep 30, 2010 | 867.74 |
| Jun 30, 2010 | 2,315.10 |